Staff report
Computed tomography (CT) is a medical imaging technique that uses X-rays and computer technology to visualize cross-sectional images of the body. CT scans provide detailed images of bones, soft tissues and blood vessels.
According to Coherent Market Insights, the global computed tomography market was valued at $7.9 billion in 2023 and is forecast to reach a value of $12.3 billion by 2030. It is expected to grow at a CAGR of 6.5% between 2023 and 2030.
Increasing collaborations among key market players is expected to drive the global computed tomography market growth over the forecast period. For instance, on April 19, 2023, Kromek Group plc, a developer of radiation detection and bio-detection technology solutions for the advanced imaging and chemical, biological, radiological, and nuclear (CBRN) detection segments, and Analogic Corporation, a health care company, announced that both companies collaborated together for the development of next-generation Cadmium Zinc Telluride (CZT) based detector solutions for Photon Counting Computed Tomography (PCCT) applications in the medical imaging and security sectors.
An increasing adoption of inorganic growth strategies such as distribution agreements among key market players is also expected to fuel the overall computed tomography market growth.
Increasing product approval is also expected to fuel market growth during the forecast period. For instance, on May 30, 2023, GE HealthCare announced that it had received an approval from the U.S. Food and Drug Administration for new deep learning solution for enhanced image quality in PET/CT (Positron Emission Tomography/Computed Tomography). Precision DL for PET/CT is the latest addition to GE HealthCare’s Effortless Recon DL portfolio of deep learning-based solutions – which also includes AIR Recon DL for MRI, TrueFidelity for CT, and Helix DL for X-ray to significantly improve image quality.
Among product types, the stationary CT scanners segment is dominant during the forecast period in the North America region.
Among applications, the oncology segment is expected will be dominate the market over the forecast period because of the increasing number of partnerships among key market players. For instance, in 2022, Xoran Technologies announced a partnership with West Virginia University (WVU) to a develop PET/CT scanner for head and neck cancers (HNCs). The partnership’s goal is to improve the ability to effectively treat head and neck cancers.
Reports from other research firms also predict growth in the global CT market.
The global computed tomography (CT) scanners market size is projected to grow from $6.95 billion in 2023 to $10.19 billion by 2030, according to Fortune Business Insights.
Precedence Research states that the global computed tomography market size was estimated at $5.68 billion in 2022 and is expected to hit around $10.92 billion by 2032 with an increased CAGR of 6.8% from 2023 to 2032.
